Viking Therapeutics Inc (VKTX)

10:45 AM

VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales - Yahoo Finance

10:45 AM

09:56 AM

Viking Therapeutics stock rating reiterated by Cantor Fitzgerald at $104 - Investing.com

09:56 AM

09:52 AM

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory - Insider Monkey

09:52 AM

03:14 AM

Viking Therapeutics Inc (VKTX) Q2 2025 Earnings Call Highlights: Navigating Increased R&D ... - Yahoo Finance

03:14 AM

02:48 AM

Is Viking Therapeutics Inc. a good long term investmentPhenomenal capital appreciation - jammulinksnews.com

02:48 AM

02:15 AM

Viking Therapeutics Inc (VKTX) Q2 2025 Earnings Call Highlights: - GuruFocus

02:15 AM

12:07 PM

Viking Therapeutics Advances Clinical Pipeline Amid Financial Losses - TipRanks

12:07 PM

Jul 23, 2025

Viking Therapeutics' Q2 2025 Earnings Call: Unpacking Key Contradictions in Phase III Study Strategy - AInvest

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics EPS miss sends shares down 7% - MSN

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics Posts Wider Q2 Loss - AOL.com

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics EPS miss sends shares down 7% (VKTX:NASDAQ) - Seeking Alpha

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates - Benzinga

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics, Inc. SEC 10-Q Report - TradingView

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics shares fall as Q2 loss exceeds estimates By Investing.com - Investing.com India

Jul 23, 2025

Jul 23, 2025

Viking (VKTX) Q2 2025 Earnings Call Transcript - Mitrade

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | VKTX Stock News - GuruFocus

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics Advances Dual Obesity Drug Strategy: Injectable Phase 3 Trials Begin as Oral Version Nears Data - Stock Titan

Jul 23, 2025

Jul 23, 2025

What analysts say about Viking Therapeutics Inc. stockSuperior stock selection - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics (VKTX) Options Activity Surges Ahead of Earnings | VKTX Stock News - GuruFocus

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics to Report Q2 2025 Financial Results on July 23, 2025 - AInvest

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics, Inc. (NASDAQ:VKTX) institutional owners may be pleased with recent gains after 38% loss over the past year - Yahoo Finance

Jul 23, 2025

Jul 23, 2025

Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025 - Finansavisen

Jul 23, 2025

Jul 22, 2025

What drives Viking Therapeutics Inc. stock priceHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Viking Therapeutics (VKTX) Set to Release Q2 Earnings Results - GuruFocus

Jul 22, 2025

Jul 22, 2025

Better Growth Buy: Eli Lilly vs. Viking Therapeutics - Mitrade

Jul 22, 2025

Jul 22, 2025

Viking Therapeutics Inc. Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect - Yahoo Finance

Jul 21, 2025

Jul 21, 2025

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - MSN

Jul 21, 2025

Jul 21, 2025

3 Monster Stocks in the Making to Buy Right Now - The Motley Fool

Jul 21, 2025

Jul 20, 2025

Viking Therapeutics VKTX 2025Q2 Earnings Preview Upside Potential Driven by Analyst Price Targets - AInvest

Jul 20, 2025

Jul 19, 2025

Viking Therapeutics (VKTX) Soars 9.7% on Looming Weight Loss Drug Trial Results - MSN

Jul 19, 2025

Jul 19, 2025

(VKTX) On The My Stocks Page - news.stocktradersdaily.com

Jul 19, 2025

Jul 18, 2025

Viking Therapeutics (VKTX) Soars 3.40% on Bullish Analyst Sentiment - AInvest

Jul 18, 2025